Objective Identify and appraise clinical practice guidelines (CPGs) for radioactive iodine
(RAI) indications in differentiated thyroid carcinoma (DTC), and the treatment for radioactive …

Objective: The goal was to determine if there was a relation between the introduction of
evidence-based radioactive iodine (RAI) treatment guidelines for differentiated thyroid …

Background: Radioactive iodine (RAI) remnant ablation has been used to eliminate normal
thyroid tissue and may also facilitate monitoring for persistent or recurrent thyroid carcinoma …

The procedure guideline for radioiodine therapy of differentiated thyroid cancer (version 4)
was developed in the consensus of a representative expert group. This fulfils the level S1 …

Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical
practice. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of
differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or …

Radioactive iodine (RAI) therapy for differentiated thyroid cancer has been successfully
used for more than 70 years. However, there is still plenty of controversy surrounding the …

Radioactive iodine (RAI) is a key component in the treatment of differentiated thyroid cancer.
RAI has been recommended more selectively in recent years as guidelines evolve to reflect …

Background: Thyroid cancer is the most common endocrine malignancy, with differentiated
thyroid cancer (DTC) comprising∼ 93% of all thyroid cancers. While most cases of DTC are …

Aim: For the examination of the impact on clinical practice of the guidelines for differentiated
thyroid carcinoma (DTC), treatment data from the ongoing Multicenter Study Differentiated …